1. Home
  2. TNXP vs VRME Comparison

TNXP vs VRME Comparison

Compare TNXP & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$10.59

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$1.05

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
VRME
Founded
2007
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
9.2M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
TNXP
VRME
Price
$10.59
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$1.50
AVG Volume (30 Days)
413.4K
4.7M
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
91.75
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
$16,398,000.00
Revenue This Year
$558.11
$36.85
Revenue Next Year
$38.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.85
N/A
52 Week Low
$9.40
$0.59
52 Week High
$25.69
$1.95

Technical Indicators

Market Signals
Indicator
TNXP
VRME
Relative Strength Index (RSI) 33.24 71.27
Support Level $10.03 $0.65
Resistance Level $12.99 $1.35
Average True Range (ATR) 0.55 0.11
MACD -0.28 0.06
Stochastic Oscillator 10.01 40.44

Price Performance

Historical Comparison
TNXP
VRME

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

Share on Social Networks: